Atypical insufficiency type femoral stress fractures in patient on bisphosphonates.
作者信息
Evangelista Peter T, Levine Scott M
机构信息
Rhode Island Hospital, Providence, RI 02903, USA.
出版信息
Med Health R I. 2012 Feb;95(2):61-2.
PMID:22474880
Abstract
摘要
相似文献
1
Atypical insufficiency type femoral stress fractures in patient on bisphosphonates.使用双膦酸盐类药物的患者发生的非典型 insufficiency 型股骨应力性骨折
Med Health R I. 2012 Feb;95(2):61-2.
2
The cumulative effect of bisphosphonates and statins on stress fractures. Is it a failure of steroid biosynthesis? Case Report.
Neuro Endocrinol Lett. 2016;37(2):97-101.
3
4
Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.在接受或未接受特立帕肽治疗的骨质疏松症患者中，与使用双膦酸盐相关的非典型转子下和股骨骨折的手术结果。
BMC Musculoskelet Disord. 2017 Dec 13;18(1):527. doi: 10.1186/s12891-017-1878-5.
5
6
Atypical femur fractures.非典型股骨骨折
J Orthop Trauma. 2014;28 Suppl 1:S36-42. doi: 10.1097/BOT.0000000000000073.
7
Atypical femoral fractures and their relation to bisphosphonate use.非典型股骨骨折及其与双膦酸盐类药物使用的关系。
Isr Med Assoc J. 2013 Aug;15(8):447-50.
8
[Osteoporosis--new therapeutic possibilities. The Danish Bone Society].[骨质疏松症——新的治疗可能性。丹麦骨科学会]
Ugeskr Laeger. 2008 Mar 17;170(12):1043.
9
What is the optimal duration of bisphosphonate therapy?双磷酸盐治疗的最佳持续时间是多久？
Cleve Clin J Med. 2011 Sep;78(9):619-30. doi: 10.3949/ccjm.78a.11022.
10
Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
Int J Lab Hematol. 2007 Oct;29(5):395-7. doi: 10.1111/j.1365-2257.2006.00860.x.
Zotero 插件